Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.73
-0.17 (-2.80%)
Jun 5, 2026, 11:34 AM EDT - Market open
Taysha Gene Therapies Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Taysha Gene Therapies stock has a consensus rating of "Strong Buy" and an average price target of $12.23. The average 1-year stock price forecast is 113.62% higher than the current stock price, while the lowest is $8.00 (+39.74%) and the highest is $19 (+231.88%).
Price Target: $12.23 (+113.62%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Taysha Gene Therapies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 10 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +74.67% | May 22, 2026 |
Unknown Analyst Bank of America Securities No rating | Bank of America Securities | Buy Reiterates $9 | Buy | Reiterates | $9 | +57.21% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $17 | Buy | Maintains | $17 | +196.94% | May 7, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Buy Maintains $11 | Buy | Maintains | $11 | +92.14% | May 7, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +109.61% | May 6, 2026 |
Financial Forecast
Revenue This Year
1.85M
from 9.77M
Decreased by -81.11%
Revenue Next Year
29.77M
from 1.85M
Increased by 1,512.64%
EPS This Year
-0.44
from -0.32
EPS Next Year
-0.44
from -0.44
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.0M | ||
| Avg | 1.8M | ||
| Low | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 53.5% | ||
| Avg | -81.1% | ||
| Low | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -0.44 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |